France’s Sanofi to buy biotech firm Synthorx for $2.5 billion
Under the deal, French Sanofi has offered to buy all the outstanding shares of Synthorx a clinical-stage biotech company focused on therapies for people …
Under the deal, French Sanofi has offered to buy all the outstanding shares of Synthorx a clinical-stage biotech company focused on therapies for people …